Dresden, Germany

Dietmar Appelhans

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2006-2018

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dietmar Appelhans: Innovator in Polypropyleneimine Dendrimers

Introduction

Dietmar Appelhans is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of polymer research, particularly in the development of innovative dendrimer structures. With a total of four patents to his name, Appelhans has focused on applications that have the potential to impact medical treatments.

Latest Patents

One of his latest patents is titled "Application of maltotriose-coated 4th generation poly(propyleneimine) dendrimer PPI-G4-OS-Mal-III." This invention relates to a method of administering a polypropyleneimine dendrimer of the fourth generation, which is coated with maltotriose. The dendrimer, designated as PPI-G4-OS-Mal-III, contains 25 to 45% of R substituents representing maltotriose residues, with the remaining R substituents being hydrogen. This innovative approach aims to enhance drug delivery systems for human subjects. Another significant patent by Appelhans is also focused on the application of the maltotriose-coated dendrimer for treating neoplastic proliferation diseases, particularly chronic lymphocytic leukemia.

Career Highlights

Throughout his career, Dietmar Appelhans has worked with esteemed institutions such as the University of Lodz and the Leibniz Institute for Polymer Research Dresden e.V. His work has been instrumental in advancing the understanding and application of dendrimer technology in medical fields.

Collaborations

Some of his notable coworkers include Ida Franiak-Pietryga and Maria Bryszewska. Their collaborative efforts have contributed to the successful development of innovative polymer solutions.

Conclusion

Dietmar Appelhans stands out as a prominent inventor in the field of polymer research, particularly with his advancements in dendrimer technology. His patents reflect a commitment to improving medical treatments through innovative applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…